Brentuximab wins accelerated approval for HL, anaplastic large cell lymphoma | HemOncToday
Links shared publicly online about this topic.
- 147total visits
Brentuximab wins accelerated approval for HL, anaplastic large cell lymphoma | HemOncToday
The FDA’s Oncologic Drugs Advisory Committee today unanimously awarded accelerated approvals for IV brentuximab vedotin to treat patient
View full resource at hemonctoday.com
Tags: Cancer, Lymphoma, Hodgkin Lymphoma, Disease and Condition, Drug, Oncology, disease
Most Recently Shared on July 14, 2011 at 8:18 pm By:
“This, to me, is the poster child for a single-arm accelerated approval indication ..." - Wyndham Wilson, MD, PhD http://bit.ly/pTKjhq
Advertisement
